CD274 and neoplasm: Although the revolution in I-O achieved with ICI was originally attributed to an enhanced T cell-mediated antitumor response, increasing evidence demonstrates that NK cells also express PD-1 and PD-L1, and that they constitute targets of ICI that results in a reinvigoration of anti-tumor NK cell effector functions.